Dehydroepiandrosterone status and efficacy of dehydroepiandrosterone supplementation for bone health in anorexia nervosa: A systematic review and meta-analysis.
anorexia nervosa
bone loss
clinical trails
dehydroepiandrosterone
hormone replacement
Journal
The International journal of eating disorders
ISSN: 1098-108X
Titre abrégé: Int J Eat Disord
Pays: United States
ID NLM: 8111226
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
revised:
30
03
2022
received:
11
01
2022
accepted:
31
03
2022
pubmed:
24
4
2022
medline:
7
6
2022
entrez:
23
4
2022
Statut:
ppublish
Résumé
This study was designed to determine the status of dehydroepiandrosterone (DHEA) in women with anorexia nervosa (AN) and to assess the efficacy of DHEA supplementation as a treatment for bone health in women with AN. Studies were retrieved from the PubMed, Embase, Cochrane Library, MEDLINE, and Scopus databases from inception to February 14, 2022. Observational studies that compared serum DHEA levels between women with AN and healthy controls were included for meta-analysis, and randomized controlled trials (RCTs) that evaluated the effects of DHEA supplementation on bone mass were reviewed. Meta-analysis of 15 cross-sectional studies revealed that patients with AN had significantly elevated serum DHEA levels (mean difference (MD) = 311.63 ng/dl; 95% confidence interval (CI), 78.01-545.25) and reduced DHEAS levels (MD = -24.90 μg/dl; 95% CI, -41.72 to -8.07) compared with healthy controls. A systematic review of seven RCTs found that DHEA monotherapy does not improve bone mineral density (BMD) compared with placebo after adjusting for weight gain. While the combination of DHEA and conjugated oral contraceptives has led to increased bone strength and decreased bone loss, the beneficial effect appears to be limited to older adolescents and adults with closed physes. Potential detrimental effects on BMD were identified in younger adolescents with open physes in one study. Due to the lack of apparent benefit of DHEA in women with AN and its potential detrimental effect on BMD in young patients with AN, current evidence does not support the use of DHEA. This study demonstrates that women with anorexia nervosa have abnormal levels of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS), which have been suggested by previous studies to play a role in the development of low bone density in this condition. However, current evidence does not support the use of DHEA as a treatment to preserve bone health in patients with anorexia nervosa given the lack of clear benefit following its use and also because of a potential detrimental effect on bone mineral density in young patients with anorexia nervosa. Este estudio fue diseñado para determinar el estado de la dehidroepiandrosterona (DHEA) en mujeres con anorexia nerviosa (AN) y para evaluar la eficacia de la suplementación con DHEA como tratamiento para la salud ósea en mujeres con AN. MÉTODO: Los estudios se obtuvieron de las bases de datos PubMed, Embase, Cochrane library, MEDLINE y Scopus desde su inicio hasta el 14 de febrero de 2022. Se incluyeron estudios observacionales que compararon los niveles séricos de DHEA entre mujeres que padecen AN y controles sanos para el metanálisis, y se revisaron los ensayos controlados aleatorios (ECA) que evaluaron los efectos de la suplementación con DHEA sobre la masa ósea. El metanálisis de 15 estudios transversales reveló que los pacientes que padecen AN tenían niveles séricos significativamente elevados de DHEA (diferencia de medias [DM] = 311,63 ng/dL; intervalo de confianza [IC] del 95%, 78,01-545,25) y niveles reducidos de DHEAS (DM = -24,90 μg/dL; IC del 95%, -41,72 a -8,07) en comparación con los controles sanos. La revisión sistemática de siete ECA encontró que la monoterapia con DHEA no mejora la densidad mineral ósea (DMO) en comparación con placebo después de ajustar el aumento de peso. Si bien la combinación de DHEA y anticonceptivos orales conjugados ha llevado a un aumento de la fuerza ósea y una disminución de la pérdida ósea, el efecto beneficioso parece limitarse a adolescentes mayores y adultos con placas de crecimiento cerradas. En un estudio se identificaron posibles efectos perjudiciales sobre la DMO en adolescentes más jóvenes con placas de crecimiento abiertas. DISCUSIÓN: Debido a la falta de beneficio aparente de la DHEA en mujeres que padecen AN y su posible efecto perjudicial sobre la DMO en pacientes jóvenes que padecen AN, la evidencia actual no apoya el uso de la DHEA.
Autres résumés
Type: Publisher
(spa)
Este estudio fue diseñado para determinar el estado de la dehidroepiandrosterona (DHEA) en mujeres con anorexia nerviosa (AN) y para evaluar la eficacia de la suplementación con DHEA como tratamiento para la salud ósea en mujeres con AN. MÉTODO: Los estudios se obtuvieron de las bases de datos PubMed, Embase, Cochrane library, MEDLINE y Scopus desde su inicio hasta el 14 de febrero de 2022. Se incluyeron estudios observacionales que compararon los niveles séricos de DHEA entre mujeres que padecen AN y controles sanos para el metanálisis, y se revisaron los ensayos controlados aleatorios (ECA) que evaluaron los efectos de la suplementación con DHEA sobre la masa ósea.
Substances chimiques
Dehydroepiandrosterone
459AG36T1B
Types de publication
Journal Article
Meta-Analysis
Review
Systematic Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
733-746Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Arlt, W., Hammer, F., Sanning, P., Butcher, S. K., Lord, J. M., Allolio, B., Annane, D., & Stewart, P. M. (2006). Dissociation of serum dehydroepiandrosterone and dehydroepiandrosterone sulfate in septic shock. The Journal of Clinical Endocrinology and Metabolism, 91(7), 2548-2554. https://doi.org/10.1210/jc.2005-2258
Baranowska, B., & Zgliczyński, S. (1982). The role of sex hormones in the mechanism of inhibited LH release in female patients with anorexia nervosa. Acta Endocrinologica, 99(3), 334-338. https://doi.org/10.1530/acta.0.0990334
Baulieu, E. E. (1996). Dehydroepiandrosterone (DHEA): A fountain of youth? The Journal of Clinical Endocrinology and Metabolism, 81(9), 3147-3151. https://doi.org/10.1210/jcem.81.9.8784058
Bloch, M., Ish-Shalom, S., Greenman, Y., Klein, E., & Latzer, Y. (2012). Dehydroepiandrosterone treatment effects on weight, bone density, bone metabolism and mood in women suffering from anorexia nervosa-a pilot study. Psychiatry Research, 200(2-3), 544-549. https://doi.org/10.1016/j.psychres.2012.07.012
Cardim, H. J., Lopes, C. M., Giannella-Neto, D., da Fonseca, A. M., & Pinotti, J. A. (2001). The insulin-like growth factor-I system and hormone replacement therapy. Fertility and Sterility, 75(2), 282-287. doi:10.1016/s0015-0282(00)01691-5
Chabraoui, L., Mathian, B., Patricot, M. C., & Revol, A. (1991). Specific assay for unconjugated dehydroepiandrosterone in human plasma by capillary gas chromatography with electron-capture detection. Journal of Chromatography, 567(2), 299-307. https://doi.org/10.1016/0378-4347(91)80136-z
Cumpston, M., Li, T., Page, M. J., Chandler, J., Welch, V. A., Higgins, J. P., & Thomas, J. (2019). Updated guidance for trusted systematic reviews: A new edition of the Cochrane handbook for systematic reviews of interventions. Cochrane Database of Systematic Reviews, 10, Ed000142. https://doi.org/10.1002/14651858.Ed000142
Devesa, J., Pérez-Fernández, R., Bokser, L., Gaudiero, G. J., Lima, L., & Casanueva, F. F. (1988). Adrenal androgen secretion and dopaminergic activity in anorexia nervosa. Hormone and Metabolic Research, 20(1), 57-60. https://doi.org/10.1055/s-2007-1010748
DiVasta, A. D., Feldman, H. A., Beck, T. J., LeBoff, M. S., & Gordon, C. M. (2014). Does hormone replacement normalize bone geometry in adolescents with anorexia nervosa? Journal of Bone and Mineral Research, 29(1), 151-157. https://doi.org/10.1002/jbmr.2005
Divasta, A. D., Feldman, H. A., Giancaterino, C., Rosen, C. J., Leboff, M. S., & Gordon, C. M. (2012). The effect of gonadal and adrenal steroid therapy on skeletal health in adolescents and young women with anorexia nervosa. Metabolism, 61(7), 1010-1020. https://doi.org/10.1016/j.metabol.2011.11.016
DiVasta, A. D., Feldman, H. A., O'Donnell, J. M., Long, J., Leonard, M. B., & Gordon, C. M. (2019). Impact of adrenal hormone supplementation on bone geometry in growing teens with anorexia nervosa. The Journal of Adolescent Health, 65(4), 462-468. doi:10.1016/j.jadohealth.2019.04.003
dos Santos, E., dos Santos, J. E., Ribeiro, R. P., Rosa, E. S. A. C., Moreira, A. C., & Silva de Sá, M. F. (2007). Absence of circadian salivary cortisol rhythm in women with anorexia nervosa. Journal of Pediatric and Adolescent Gynecology, 20(1), 13-18. https://doi.org/10.1016/j.jpag.2006.10.011
Duval, S., & Tweedie, R. (2000). Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56(2), 455-463. https://doi.org/10.1111/j.0006-341x.2000.00455.x
Egger, M., Davey Smith, G., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315(7109), 629-634. https://doi.org/10.1136/bmj.315.7109.629
Estour, B., Germain, N., Diconne, E., Frere, D., Cottet-Emard, J. M., Carrot, G., Lang, F., & Galusca, B. (2010). Hormonal profile heterogeneity and short-term physical risk in restrictive anorexia nervosa. The Journal of Clinical Endocrinology and Metabolism, 95(5), 2203-2210. https://doi.org/10.1210/jc.2009-2608
Fazeli, P. K., & Klibanski, A. (2014). Anorexia nervosa and bone metabolism. Bone, 66, 39-45. https://doi.org/10.1016/j.bone.2014.05.014
Fazeli, P. K., & Klibanski, A. (2018). Effects of anorexia nervosa on bone metabolism. Endocrine Reviews, 39(6), 895-910. https://doi.org/10.1210/er.2018-00063
Galusca, B., Bossu, C., Germain, N., Kadem, M., Frere, D., Lafage-Proust, M. H., Lang, F., & Estour, B. (2006). Age-related differences in hormonal and nutritional impact on lean anorexia nervosa bone turnover uncoupling. Osteoporosis International, 17(6), 888-896. https://doi.org/10.1007/s00198-005-0063-0
Galusca, B., Leca, V., Germain, N., Frere, D., Khalfallah, Y., Lang, F., & Estour, B. (2012). Normal inhibin B levels suggest partial preservation of gonadal function in adult male patients with anorexia nervosa. The Journal of Sexual Medicine, 9(5), 1442-1447. https://doi.org/10.1111/j.1743-6109.2011.02514.x
Gordon, C. M., Grace, E., Emans, S. J., Feldman, H. A., Goodman, E., Becker, K. A., Rosen, C. J., Gundberg, C. M., & LeBoff, M. S. (2002). Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: A randomized trial. The Journal of Clinical Endocrinology and Metabolism, 87(11), 4935-4941. https://doi.org/10.1210/jc.2002-020545
Gordon, C. M., Grace, E., Emans, S. J., Goodman, E., Crawford, M. H., & Leboff, M. S. (1999). Changes in bone turnover markers and menstrual function after short-term oral DHEA in young women with anorexia nervosa. Journal of Bone and Mineral Research, 14(1), 136-145. https://doi.org/10.1359/jbmr.1999.14.1.136
Gurnell, E. M., Hunt, P. J., Curran, S. E., Conway, C. L., Pullenayegum, E. M., Huppert, F. A., Compston, J. E., Herbert, J., & Chatterjee, V. K. (2008). Long-term DHEA replacement in primary adrenal insufficiency: A randomized, controlled trial. The Journal of Clinical Endocrinology and Metabolism, 93(2), 400-409. https://doi.org/10.1210/jc.2007-1134
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., DeBeer, H., Jaeschke, R., Rind, D., Meerpohl, J., Dahm, P., & Schünemann, H. J. (2011). GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology, 64(4), 383-394. https://doi.org/10.1016/j.jclinepi.2010.04.026
Hammer, F., Subtil, S., Lux, P., Maser-Gluth, C., Stewart, P. M., Allolio, B., & Arlt, W. (2005). No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: In vivo and in vitro studies. The Journal of Clinical Endocrinology and Metabolism, 90(6), 3600-3605. https://doi.org/10.1210/jc.2004-2386
Hedman, M., Nilsson, E., & de la Torre, B. (1989). Low sulpho-conjugated steroid hormone levels in systemic lupus erythematosus (SLE). Clinical and Experimental Rheumatology, 7(6), 583-588.
Higgins, J. P., Altman, D. G., Gøtzsche, P. C., Jüni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A., Cochrane Bias Methods Group, & Cochrane Statistical Methods Group. (2011). The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ, 343, d5928. https://doi.org/10.1136/bmj.d5928
Higgins, J. P., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in meta-analyses. BMJ, 327(7414), 557-560. https://doi.org/10.1136/bmj.327.7414.557
Jagielska, G. W., Przedlacki, J., Bartoszewicz, Z., & Racicka, E. (2016). Bone mineralization disorders as a complication of anorexia nervosa - etiology, prevalence, course and treatment. Psychiatria Polska, 50(3), 509-520. https://doi.org/10.12740/pp/59289
Jankowski, C. M., Gozansky, W. S., Schwartz, R. S., Dahl, D. J., Kittelson, J. M., Scott, S. M., Van Pelt, R. E., & Kohrt, W. M. (2006). Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: A randomized, controlled trial. The Journal of Clinical Endocrinology and Metabolism, 91(8), 2986-2993. https://doi.org/10.1210/jc.2005-2484
Jayasinghe, Y., Grover, S. R., & Zacharin, M. (2008). Current concepts in bone and reproductive health in adolescents with anorexia nervosa. BJOG, 115(3), 304-315. https://doi.org/10.1111/j.1471-0528.2007.01601.x
Kam, G. Y., Leung, K. C., Baxter, R. C., & Ho, K. K. (2000). Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex. The Journal of Clinical Endocrinology and Metabolism, 85(5), 1918-1922. https://doi.org/10.1210/jcem.85.5.6527
Kim, M. S., Shigenaga, J., Moser, A., Grunfeld, C., & Feingold, K. R. (2004). Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response. American Journal of Physiology. Endocrinology and Metabolism, 287(4), E731-E738. https://doi.org/10.1152/ajpendo.00130.2004
Kirby, D. J., Buchalter, D. B., Anil, U., & Leucht, P. (2020). DHEA in bone: The role in osteoporosis and fracture healing. Archives of Osteoporosis, 15(1), 84. https://doi.org/10.1007/s11657-020-00755-y
Kirchengast, S., & Huber, J. (2004). Body composition characteristics and fat distribution patterns in young infertile women. Fertility and Sterility, 81(3), 539-544. https://doi.org/10.1016/j.fertnstert.2003.08.018
Kurita, H., Maeshima, H., Kida, S., Matsuzaka, H., Shimano, T., Nakano, Y., Baba, H., Suzuki, T., & Arai, H. (2013). Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls. Journal of Affective Disorders, 146(2), 205-212. https://doi.org/10.1016/j.jad.2012.09.004
Lawson, E. A., Misra, M., Meenaghan, E., Rosenblum, L., Donoho, D. A., Herzog, D., Klibanski, A., & Miller, K. K. (2009). Adrenal glucocorticoid and androgen precursor dissociation in anorexia nervosa. The Journal of Clinical Endocrinology and Metabolism, 94(4), 1367-1371. https://doi.org/10.1210/jc.2008-2558
Lemmen, J. G., van den Brink, C. E., Legler, J., van der Saag, P. T., & van der Burg, B. (2002). Detection of oestrogenic activity of steroids present during mammalian gestation using oestrogen receptor alpha- and oestrogen receptor beta-specific in vitro assays. The Journal of Endocrinology, 174(3), 435-446. https://doi.org/10.1677/joe.0.1740435
Liang, X., Glowacki, J., Hahne, J., Xie, L., LeBoff, M. S., & Zhou, S. (2016). Dehydroepiandrosterone stimulation of Osteoblastogenesis in human MSCs requires IGF-I signaling. Journal of Cellular Biochemistry, 117(8), 1769-1774. https://doi.org/10.1002/jcb.25475
Lin, H., Li, L., Wang, Q., Wang, Y., Wang, J., & Long, X. (2019). A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA supplementation of bone mineral density in healthy adults. Gynecological Endocrinology, 35(11), 924-931. https://doi.org/10.1080/09513590.2019.1616175
Lucas, A. R., Melton, L. J., 3rd, Crowson, C. S., & O'Fallon, W. M. (1999). Long-term fracture risk among women with anorexia nervosa: A population-based cohort study. Mayo Clinic Proceedings, 74(10), 972-977. https://doi.org/10.4065/74.10.972
Ma, L. L., Wang, Y. Y., Yang, Z. H., Huang, D., Weng, H., & Zeng, X. T. (2020). Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: What are they and which is better? Military Medical Research, 7(1), 7. https://doi.org/10.1186/s40779-020-00238-8
Miller, K. K. (2013). Endocrine effects of anorexia nervosa. Endocrinology and Metabolism Clinics of North America, 42(3), 515-528. https://doi.org/10.1016/j.ecl.2013.05.007
Miller, K. K., Lawson, E. A., Mathur, V., Wexler, T. L., Meenaghan, E., Misra, M., Herzog, D. B., & Klibanski, A. (2007). Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. The Journal of Clinical Endocrinology and Metabolism, 92(4), 1334-1339. https://doi.org/10.1210/jc.2006-2501
Milos, G., Spindler, A., Rüegsegger, P., Hasler, G., Schnyder, U., Laib, A., Gallo, L. M., Uebelhart, D., & Häuselmann, H. (2007). Does weight gain induce cortical and trabecular bone regain in anorexia nervosa? A two-year prospective study. Bone, 41(5), 869-874. https://doi.org/10.1016/j.bone.2007.07.017
Misra, M., Katzman, D., Miller, K. K., Mendes, N., Snelgrove, D., Russell, M., Goldstein, M. A., Ebrahimi, S., Clauss, L., Weigel, T., Mickley, D., Schoenfeld, D. A., Herzog, D. B., & Klibanski, A. (2011). Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. Journal of Bone and Mineral Research, 26(10), 2430-2438. https://doi.org/10.1002/jbmr.447
Misra, M., Soyka, L. A., Miller, K. K., Grinspoon, S., Levitsky, L. L., & Klibanski, A. (2003). Regional body composition in adolescents with anorexia nervosa and changes with weight recovery. The American Journal of Clinical Nutrition, 77(6), 1361-1367. https://doi.org/10.1093/ajcn/77.6.1361
Misra, M., Soyka, L. A., Miller, K. K., Herzog, D. B., Grinspoon, S., De Chen, D., Neubauer, G., & Klibanski, A. (2003). Serum osteoprotegerin in adolescent girls with anorexia nervosa. The Journal of Clinical Endocrinology and Metabolism, 88(8), 3816-3822. https://doi.org/10.1210/jc.2003-030088
Monteleone, P., Luisi, M., Colurcio, B., Casarosa, E., Monteleone, P., Ioime, R., Genazzani, A. R., & Maj, M. (2001). Plasma levels of neuroactive steroids are increased in untreated women with anorexia nervosa or bulimia nervosa. Psychosomatic Medicine, 63(1), 62-68. https://doi.org/10.1097/00006842-200101000-00008
Monteleone, P., Luisi, M., Martiadis, V., Serritella, C., Longobardi, N., Casarosa, E., Genazzani, A. R., & Maj, M. (2006). Impaired reduction of enhanced levels of dehydroepiandrosterone by oral dexamethasone in anorexia nervosa. Psychoneuroendocrinology, 31(4), 537-542. https://doi.org/10.1016/j.psyneuen.2005.08.015
Moola S, M. Z., Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi R, Mattis P, Lisy K, Mu P-F. (2017). Chapter 7: Systematic reviews of etiology and risk. From the Joanna Briggs institute https://reviewersmanual.joannabriggs.org/
Murakami, K., Nakagawa, T., Yamashiro, G., Araki, K., & Akasofu, K. (1993). Levels of androgens and danazol metabolites in serum during danazol therapy. Fertility and Sterility, 60(1), 179-181.
Nagata, J. M., Golden, N. H., Leonard, M. B., Copelovitch, L., & Denburg, M. R. (2017). Assessment of sex differences in fracture risk among patients with anorexia nervosa: A population-based cohort study using the health improvement network. Journal of Bone and Mineral Research, 32(5), 1082-1089. https://doi.org/10.1002/jbmr.3068
Nair, K. S., Rizza, R. A., O'Brien, P., Dhatariya, K., Short, K. R., Nehra, A., Vittone, J. L., Klee, G. G., Basu, A., Basu, R., Cobelli, C., Toffolo, G., Dalla Man, C., Tindall, D. J., Melton, L. J., 3rd, Smith, G. E., Khosla, S., & Jensen, M. D. (2006). DHEA in elderly women and DHEA or testosterone in elderly men. The New England Journal of Medicine, 355(16), 1647-1659. https://doi.org/10.1056/NEJMoa054629
Nestler, J. E., Beer, N. A., Jakubowicz, D. J., & Beer, R. M. (1994). Effects of a reduction in circulating insulin by metformin on serum dehydroepiandrosterone sulfate in nondiabetic men. The Journal of Clinical Endocrinology and Metabolism, 78(3), 549-554. https://doi.org/10.1210/jcem.78.3.8126125
Noordam, C., Dhir, V., McNelis, J. C., Schlereth, F., Hanley, N. A., Krone, N., Smeitink, J. A., Smeets, R., Sweep, F. C., Claahsen-van der Grinten, H. L., & Arlt, W. (2009). Inactivating PAPSS2 mutations in a patient with premature pubarche. The New England Journal of Medicine, 360(22), 2310-2318. https://doi.org/10.1056/NEJMoa0810489
Ohlsson, C., Nethander, M., Karlsson, M. K., Rosengren, B. E., Ribom, E., Mellström, D., & Vandenput, L. (2018). Serum DHEA and its sulfate are associated with incident fall risk in older men: The MrOS Sweden study. Journal of Bone and Mineral Research, 33(7), 1227-1232. https://doi.org/10.1002/jbmr.3418
Ohlsson, C., Nethander, M., Kindmark, A., Ljunggren, Ö., Lorentzon, M., Rosengren, B. E., Karlsson, M. K., Mellström, D., & Vandenput, L. (2017). Low serum DHEAS predicts increased fracture risk in older men: The MrOS Sweden study. Journal of Bone and Mineral Research, 32(8), 1607-1614. https://doi.org/10.1002/jbmr.3123
Ostrowska, Z., Ziora, K., Oświęcimska, J., Swiętochowska, E., & Wołkowska-Pokrywa, K. (2012). Dehydroepiandrosterone sulfate, osteoprotegerin and its soluble ligand sRANKL and bone metabolism in girls with anorexia nervosa. Postȩpy Higieny i Medycyny Doświadczalnej (Online), 66, 655-662. https://doi.org/10.5604/17322693.1009971
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., McGuinness, L. A., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
Prough, R. A., Clark, B. J., & Klinge, C. M. (2016). Novel mechanisms for DHEA action. Journal of Molecular Endocrinology, 56(3), R139-R155. https://doi.org/10.1530/jme-16-0013
Sim, L. A., McGovern, L., Elamin, M. B., Swiglo, B. A., Erwin, P. J., & Montori, V. M. (2010). Effect on bone health of estrogen preparations in premenopausal women with anorexia nervosa: A systematic review and meta-analyses. The International Journal of Eating Disorders, 43(3), 218-225. https://doi.org/10.1002/eat.20687
Sirinathsinghji, D. J., & Mills, I. H. (1985). Concentration patterns of plasma dehydroepiandrosterone, delta 5-androstenediol and their sulphates, testosterone and cortisol in normal healthy women and in women with anorexia nervosa. Acta Endocrinologica, 108(2), 255-260. https://doi.org/10.1530/acta.0.1080255
Soyka, L. A., Grinspoon, S., Levitsky, L. L., Herzog, D. B., & Klibanski, A. (1999). The effects of anorexia nervosa on bone metabolism in female adolescents. The Journal of Clinical Endocrinology and Metabolism, 84(12), 4489-4496. https://doi.org/10.1210/jcem.84.12.6207
Soyka, L. A., Misra, M., Frenchman, A., Miller, K. K., Grinspoon, S., Schoenfeld, D. A., & Klibanski, A. (2002). Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. The Journal of Clinical Endocrinology and Metabolism, 87(9), 4177-4185. https://doi.org/10.1210/jc.2001-011889
Stein, D., Maayan, R., Ram, A., Loewenthal, R., Achiron, A., Modan-Moses, D., Feigin, M., Weizman, A., & Valevski, A. (2005). Circulatory neurosteroid levels in underweight female adolescent anorexia nervosa inpatients and following weight restoration. European Neuropsychopharmacology, 15(6), 647-653. https://doi.org/10.1016/j.euroneuro.2005.05.001
Strott, C. A. (2002). Sulfonation and molecular action. Endocrine Reviews, 23(5), 703-732. https://doi.org/10.1210/er.2001-0040
Sulcová, J., Hill, M., Hampl, R., & Stárka, L. (1997). Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects. The Journal of Endocrinology, 154(1), 57-62. https://doi.org/10.1677/joe.0.1540057
Sun, Y., Mao, M., Sun, L., Feng, Y., Yang, J., & Shen, P. (2002). Treatment of osteoporosis in men using dehydroepiandrosterone sulfate. Chinese Medical Journal, 115(3), 402-404.
Thompson, S. G., & Sharp, S. J. (1999). Explaining heterogeneity in meta-analysis: A comparison of methods. Statistics in Medicine, 18(20), 2693-2708. https://doi.org/10.1002/(sici)1097-0258(19991030)18:20<2693::aid-sim235>3.0.co;2-v
Traish, A. M., Kang, H. P., Saad, F., & Guay, A. T. (2011). Dehydroepiandrosterone (DHEA)--a precursor steroid or an active hormone in human physiology. The Journal of Sexual Medicine, 8(11), 2960-2982. https://doi.org/10.1111/j.1743-6109.2011.02523.x
Turcu, A. F., Rege, J., Auchus, R. J., & Rainey, W. E. (2020). 11-oxygenated androgens in health and disease. Nature Reviews. Endocrinology, 16(5), 284-296. https://doi.org/10.1038/s41574-020-0336-x
Vajapeyam, S., Ecklund, K., Mulkern, R. V., Feldman, H. A., O'Donnell, J. M., DiVasta, A. D., Rosen, C. J., & Gordon, C. M. (2018). Magnetic resonance imaging and spectroscopy evidence of efficacy for adrenal and gonadal hormone replacement therapy in anorexia nervosa. Bone, 110, 335-342. https://doi.org/10.1016/j.bone.2018.02.021
Villareal, D. T., Holloszy, J. O., & Kohrt, W. M. (2000). Effects of DHEA replacement on bone mineral density and body composition in elderly women and men. Clinical Endocrinology, 53(5), 561-568. https://doi.org/10.1046/j.1365-2265.2000.01131.x
von Mühlen, D., Laughlin, G. A., Kritz-Silverstein, D., Bergstrom, J., & Bettencourt, R. (2008). Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: The DAWN trial. Osteoporosis International, 19(5), 699-707. https://doi.org/10.1007/s00198-007-0520-z
Wan, X., Wang, W., Liu, J., & Tong, T. (2014). Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Medical Research Methodology, 14, 135. https://doi.org/10.1186/1471-2288-14-135
Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C., Her, C., & Raftogianis, R. B. (1997). Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. The FASEB Journal, 11(1), 3-14.
Weiss, E. P., Shah, K., Fontana, L., Lambert, C. P., Holloszy, J. O., & Villareal, D. T. (2009). Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone. The American Journal of Clinical Nutrition, 89(5), 1459-1467. https://doi.org/10.3945/ajcn.2008.27265
Weissberger, A. J., Ho, K. K., & Lazarus, L. (1991). Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. The Journal of Clinical Endocrinology and Metabolism, 72(2), 374-381. https://doi.org/10.1210/jcem-72-2-374
Winterer, J., Gwirtsman, H. E., George, D. T., Kaye, W. H., Loriaux, D. L., & Cutler, G. B., Jr. (1985). Adrenocorticotropin-stimulated adrenal androgen secretion in anorexia nervosa: Impaired secretion at low weight with normalization after long-term weight recovery. The Journal of Clinical Endocrinology and Metabolism, 61(4), 693-697. https://doi.org/10.1210/jcem-61-4-693
Yamamotova, A., Kmoch, V., & Papezova, H. (2012). Role of dehydroepiandrosterone and cortisol in nociceptive sensitivity to thermal pain in anorexia nervosa and healthy women. Neuro Endocrinology Letters, 33(4), 401-405.
Zumoff, B., Walsh, B. T., Katz, J. L., Levin, J., Rosenfeld, R. S., Kream, J., & Weiner, H. (1983). Subnormal plasma dehydroisoandrosterone to cortisol ratio in anorexia nervosa: A second hormonal parameter of ontogenic regression. The Journal of Clinical Endocrinology and Metabolism, 56(4), 668-672. https://doi.org/10.1210/jcem-56-4-668